- Worldwide net sales grew 4 percent
to $1.3 billion compared to $1.2 billion the prior year
period
- Adjusted1 EPS
increased 3 percent to $1.45 per diluted share compared to $1.41
per diluted share the prior year. Reported EPS of $0.13 per diluted
share compared to $1.32 per diluted share in the prior
year
- Excluding Venezuela, net sales and
volume for the company increased 7 percent and 3 percent,
respectively, compared to the same period in 2013
- Global expansion of marketing plan
enhancements to improve productivity, activity and retention of our
members, driving a more consistent and sustainable growth
model
Herbalife Ltd. (NYSE: HLF) today reported third quarter net
sales of $1.3 billion, reflecting an increase of 4 percent compared
to the same period in 2013. Adjusted1 net income for the quarter
was $125.1 million, or $1.45 per diluted share, compared to $152.1
million, or $1.41 per diluted share for the same period in 2013. On
a reported basis, the company announced third quarter net income of
$11.2 million, or $0.13 per diluted share, compared to $142.0
million, or $1.32 per diluted share for the same period in
2013.
Third quarter 2014 reported net income was negatively impacted
by $139.5 million in pre-tax charges, or $0.97 per diluted share
after tax, related to the remeasurement of Venezuelan Bolivar
denominated assets and liabilities at the SICAD I and SICAD II
rates, and $17.5 million in pre-tax charges, or $0.13 per diluted
share after tax related to a legal reserve.
For the quarter that ended September 30, 2014, the company
generated $101.9 million net operating cash flow, and purchases of
property, plant and equipment in the period were $34.5 million.
Michael Johnson, chairman and CEO stated, “In the quarter we saw
volume increases in two-thirds of our 91 countries, especially
Russia and China. Excluding the impact of currency translation in
Venezuela, the company had solid increases in both volume and net
sales. We continue to implement initiatives that we believe will
further strengthen our foundation and drive long-term improvements
in activity, productivity and retention of our Sales Leaders. We
are proud of our members’ ability to grow the business in the short
term while embracing changes that we believe will enhance the
long-term opportunity.”
_______________
1 See Schedule A – “Reconciliation of Non-GAAP Financial
Measures” for more detail.
Mr. Johnson continued, “The changes we are applying globally,
such as first order limits, have been tested in key markets and
proven to drive positive results in terms of long term sustainable
growth. China, Russia and parts of Europe are all great examples of
markets that are stronger now than they were before we implemented
such changes.
“While these initiatives may continue to moderate near-term
volumes and sales growth, we know from our experience in those
markets that have already adopted them, that they enhance the
experience of our members and their customers, and position us for
even greater future success. Our industry-leading Gold Standard
consumer protections, changes designed to encourage our newest
members to grow their businesses prudently, and a focus on growing
a customer base of life-long customers all help our members become
more productive and successful leaders. We know that these
initiatives work, and coupled with the strength of our business
model, the efficacy of our products and the power of our brand,
will lead the company into its next phase of growth.”
Third Quarter 2014 Key Metrics2,3
Regional Volume Point and Average
Active Sales Leader Metrics
Volume Points (Mil) Average Active
Sales Leaders Region 3Q'14 Yr/Yr % Chg
3Q'14 Yr/Yr % Chg North America 303.0
(4%)
77,218 4% Asia Pacific (ex. China) 304.5 3% 76,649 5% EMEA
199.0 15% 59,668 18% Mexico 218.7 (0%) 66,977 4% South &
Central America 204.4 (17%) 64,279 7% China 120.7 24%
19,550 23%
Worldwide Total
1,350.3 0% 352,248
8% Regional Net Sales and FX Impact
Reported Net Sales (in Growth/Decline
Growth/Decline Region thousands) including FX
excluding FX North America $ 223,474 (2.3%) (2.2%) Asia Pacific
(ex. China) $ 297,896 4.9% 2.0% EMEA $ 204,428 12.5% 15.2% Mexico $
143,927 1.9% 3.5% South & Central America $ 205,211 (14.9%)
(1.1%) China $ 181,228 32.6% 33.5% Worldwide
Total $ 1,256,164 3.5% 6.3%
_______________
2 Supplemental tables that include additional business metrics
can be found at http://www.ir.herbalife.com.
3 Worldwide Average Active Sales Leaders may not equal the sum
of the Average Active Sales Leaders in each region due to the
calculation being an average of Sales Leaders active in a period,
not a summation, and the fact that some sales leaders are active in
more than one region but are counted only once in the worldwide
amount.
Outlook
Guidance for fourth quarter FY’14 includes an unfavorable impact
from currency rates of approximately $0.31 compared to the prior
year, inclusive of approximately $0.22 from Venezuela. Guidance for
FY’15 includes a currency headwind of approximately $0.66,
including approximately $0.45 from Venezuela.
Based on current business trends the company’s fourth quarter
fiscal 2014 and full year fiscal 2015 guidance is as follows.
Three Months Ending Twelve Months Ending December 31,
2014 December 31, 2014
Low
High
Low
High
Volume Point Growth vs 2013, ex. VZ 0.0% 3.0% 5.0% 6.0% Volume
Point Growth vs 2013 (3.0%) 0.0% 2.7% 3.5% Net Sales Growth vs 2013
(8.0%) (5.0%) 3.5% 4.3% Currency Adjusted Net Sales Growth vs 2013
1.0% 4.0% NA NA Diluted EPS, excluding items $1.30 $1.40 $5.80
$5.90 Currency Adjusted EPS $1.61 $1.71 NA NA Cap Ex ($ millions)
$52.0 $62.0 $170.0 $180.0 Effective Tax Rate 27.0% 29.0% 27.5%
29.5% Twelve Months Ending December 31, 2015
Low
High
Volume Point Growth vs 2014 0.0% 3.0% Net Sales Growth vs 2014
(1.0%) 2.0% Currency Adjusted Net Sales Growth vs 2014 3.0% 6.0%
Diluted EPS $5.45 $5.75 Currency Adjusted EPS $6.10 $6.40 Cap Ex ($
millions) $145.0 $165.0 Effective Tax Rate 27.0% 29.0% Free Cash
Flow ($ millions) $470.0 $500.0
Guidance excludes the impact of expenses primarily related to
legal and advisory services relating to the company’s ongoing
business matters, expenses related to an FTC inquiry, and the
impact of non-cash interest costs associated with the company’s
Convertible Notes and the expenses incurred related to the effort
to recover costs related to the reaudits that occurred last year.
Forward guidance is based on the average daily exchange rates of
the first two weeks of October. Included in the guidance is the use
of the GAAP rate for Venezuela of 50 to 1 for the balance of the
year and all of 2015 and excludes the potential impact of future
devaluation of the Venezuelan Bolivar and future repatriation, if
any, of existing cash balances in Venezuela.
Third Quarter 2014 Earnings Conference Call
Herbalife senior management will host an investor conference
call to discuss its recent financial results and provide an update
on current business trends on Tuesday, November 4, 2014 at 8 a.m.
PST (11 a.m. EST).
The dial-in number for this conference call for domestic callers
is (877) 317-1296 and (706) 634-5671 for international callers
(conference ID 7788487). Live audio of the conference call will be
simultaneously webcast in the investor relations section of the
company's website at http://ir.herbalife.com.
An audio replay will be available following the completion of
the conference call in MP3 format or by dialing (855) 859-2056 for
domestic callers or (404) 537-3406 for international callers
(conference ID 7788487). The webcast of the teleconference will be
archived and available on Herbalife's website.
About Herbalife Ltd.
Herbalife Ltd. (NYSE:HLF) is a global nutrition company
that sells weight-management, nutrition, and personal care products
intended to support a healthy lifestyle. Herbalife products
are sold in more than 90 countries through and to a network of
independent members. The company supports the Herbalife Family
Foundation and its Casa Herbalife program to help bring good
nutrition to children. Herbalife's website contains a
significant amount of information about Herbalife, including
financial and other information for investors
at http://ir.Herbalife.com. The company encourages investors
to visit its website from time to time, as information is updated
and new information is posted.
FORWARD-LOOKING STATEMENTS
Although we believe that the expectations reflected in any of
our forward-looking statements are reasonable, actual results could
differ materially from those projected or assumed in any of our
forward-looking statements. Our future financial condition and
results of operations, as well as any forward-looking statements,
are subject to change and to inherent risks and uncertainties, such
as those disclosed or incorporated by reference in our filings with
the Securities and Exchange Commission. Important factors that
could cause our actual results, performance and achievements, or
industry results to differ materially from estimates or projections
contained in our forward-looking statements include, among others,
the following:
- our relationship with, and our ability
to influence the actions of, our Members;
- improper action by our employees or
Members in violation of applicable law;
- adverse publicity associated with our
products or network marketing organization, including our ability
to comfort the marketplace and regulators regarding our compliance
with applicable laws;
- changing consumer preferences and
demands;
- our reliance upon, or the loss or
departure of any member of, our senior management team which could
negatively impact our Member relations and operating results;
- the competitive nature of our
business;
- regulatory matters governing our
products, including potential governmental or regulatory actions
concerning the safety or efficacy of our products and network
marketing program, including the direct selling market in which we
operate;
- legal challenges to our network
marketing program;
- risks associated with operating
internationally and the effect of economic factors, including
foreign exchange, inflation, disruptions or conflicts with our
third party importers, pricing and currency devaluation risks,
especially in countries such as Venezuela;
- uncertainties relating to the
application of transfer pricing, duties, value added taxes, and
other tax regulations, and changes thereto;
- uncertainties relating to
interpretation and enforcement of legislation in China governing
direct selling;
- uncertainties relating to the
interpretation, enforcement or amendment of legislation in India
governing direct selling;
- our inability to obtain the necessary
licenses to expand our direct selling business in China;
- adverse changes in the Chinese economy,
Chinese legal system or Chinese governmental policies;
- our dependence on increased penetration
of existing markets;
- contractual limitations on our ability
to expand our business;
- our reliance on our information
technology infrastructure and outside manufacturers;
- the sufficiency of trademarks and other
intellectual property rights;
- product concentration;
- changes in tax laws, treaties or
regulations, or their interpretation;
- taxation relating to our Members;
- product liability claims;
- whether we will purchase any of our
shares in the open markets or otherwise; and
- share price volatility related to,
among other things, speculative trading and certain traders
shorting our common shares.
We do not undertake any obligation to update or release any
revisions to any forward-looking statement or to report any events
or circumstances after the date hereof or to reflect the occurrence
of unanticipated events, except as required by law.
RESULTS OF OPERATIONS:
Herbalife Ltd. and Subsidiaries Condensed Consolidated Statements
of Income (In thousands, except per share amounts) (Unaudited)
Three Months Ended Nine Months Ended
9/30/2014
9/30/2013
9/30/2014
9/30/2013
North America $ 223,474 $ 228,660 $ 721,935 $ 697,697 Mexico
143,927 141,243 435,248 419,770 South and Central America 205,211
241,235 653,186 683,112 EMEA 204,428 181,738 642,933 537,609 Asia
Pacific 297,896 284,017 884,583 895,003 China 181,228
136,650 487,128 323,238 Worldwide net sales
1,256,164 1,213,543 3,825,013 3,556,429 Cost of Sales (1)
254,941 238,415 763,327 711,616 Gross
Profit 1,001,223 975,128 3,061,686 2,844,813 Royalty Overrides
363,859 373,241 1,136,452 1,116,821 Selling, General and
Administrative Expenses (2) 609,722 409,747
1,573,701 1,174,574 Operating Income 27,642 192,140
351,533 553,418 Interest Expense, net 19,864 4,726 56,231 15,658
Other Expense, net (3) 9,831 - 12,992
- (Loss) Income before income taxes (2,053 ) 187,414 282,310
537,760 Income Taxes (13,301 ) 45,464 76,902
133,775 Net Income 11,248 141,950
205,408 403,985 Basic Shares 81,927 102,200
87,754 103,096 Diluted Shares 86,201 107,777 92,619 107,759
Basic EPS $ 0.14 $ 1.39 $ 2.34 $ 3.92 Diluted EPS $ 0.13
$ 1.32 $ 2.22 $ 3.75 Dividends declared per share $ -
$ 0.30 $ 0.30 $ 0.90
(1) As discussed in Note 2 of the
quarterly report on Form 10-Q for the quarter ended September 30,
2014, Cost of Sales includes $7.6 million of inventory write downs
related to Venezuela.
(2) As discussed in Note 2 of the
quarterly report on Form 10-Q for the quarter ended September 30,
2014, Selling, General and Administrative Expenses includes $17.1
million and $98.0 million pre-tax unfavorable impact related to the
remeasurement of Venezuela Bolivar-denominated assets and
liabilities at the SICAD I and SICAD II rate, respectively, and
$7.0 million loss on Venezuela asset impairment for the three
months ended September 30, 2014; and includes $103.4 million and
$98.0 million pre-tax unfavorable impact related to the
remeasurement of Venezuela Bolivar-denominated assets and
liabilities at the SICAD I and SICAD II rate, respectively, and
$7.0 million loss on Venezuela asset impairment for the nine months
ended September 30, 2014.
(3) As discussed in Note 2 of the
quarterly report on Form 10-Q for the quarter ended September 30,
2014, Other Expense, net relates to the impairment of investments
in Bolivar-denominated bonds.
Herbalife Ltd. and Subsidiaries Condensed Consolidated
Balance Sheets (In thousands) (Unaudited) Sep 30,
Dec 31,
2014
2013
ASSETS Current Assets: Cash & cash equivalents $ 678,134
$ 972,974 Receivables, net 100,560 100,326 Inventories 367,827
351,201 Prepaid expenses and other current assets 208,589 148,774
Deferred income taxes 81,722 69,845
Total Current Assets 1,436,832 1,643,120 Property, net
358,983 318,860 Deferred compensation plan assets 27,102 26,821
Deferred financing cost, net 23,837 4,896 Other assets 101,730
63,713 Marketing related intangibles and other intangible assets,
net 310,524 310,801 Goodwill 105,490 105,490
Total Assets $ 2,364,498 $ 2,473,701
LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities:
Accounts payable $ 93,561 $ 82,665 Royalty overrides 257,775
266,952 Accrued compensation 85,451 111,905 Accrued expenses
273,074 267,501 Current portion of long-term debt 100,000 81,250
Advance sales deposits 89,499 68,079 Income taxes payable
28,674 43,826 Total Current Liabilities
928,034 922,178 Non-current liabilities Long-term debt, net
of current portion 1,727,919 850,019 Deferred compensation plan
liability 41,805 37,226 Deferred income taxes 25,719 66,026 Other
non-current liabilities 61,582 46,806
Total Liabilities 2,785,059 1,922,255 Contingencies
Shareholders' (deficit) equity: Common shares 92 101 Paid-in
capital in excess of par value 406,822 323,860 Accumulated other
comprehensive loss (58,785 ) (19,794 ) (Accumulated deficit)
retained earnings (768,690 ) 247,279 Total
Shareholders' (Deficit) Equity (420,561 ) 551,446
Total Liabilities and Shareholders' (Deficit)
Equity $ 2,364,498 $ 2,473,701 Herbalife Ltd.
and Subsidiaries Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Nine Months Ended
9/30/2014
9/30/2013
CASH FLOWS FROM OPERATING ACTIVITIES Net income $ 205,408 $ 403,985
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation and amortization 69,191 63,207 (Excess) deficiency in
tax benefits from share-based payment arrangements (4,176 ) 2,586
Share-based compensation expenses 34,431 21,882 Non-cash interest
expense 31,179 1,937 Deferred income taxes (59,022 ) (7,532 )
Inventory write-downs 17,729 17,536 Unrealized foreign exchange
transaction loss (gain) 4,032 585 Foreign exchange loss relating to
Venezuela 200,294 15,116 Impairments and write-downs relating to
Venezuela 27,514 - Other 3,060 1,661 Changes in operating assets
and liabilities: Receivables (5,388 ) 1,624 Inventories (58,724 )
(37,311 ) Prepaid expenses and other current assets (59,211 )
(15,330 ) Other assets (8,794 ) (678 ) Accounts payable 15,407
8,569 Royalty overrides 4,385 13,959 Accrued expenses and accrued
compensation 11,822 65,868 Advance sales deposits 27,446 27,038
Income taxes (11,665 ) (13,313 ) Deferred compensation plan
liability 4,579 5,595 NET CASH PROVIDED
BY OPERATING ACTIVITIES 449,497 576,984
CASH FLOWS FROM INVESTING ACTIVITIES Purchases of property, plant
and equipment (139,970 ) (91,782 ) Proceeds from sale of property,
plant and equipment 23 121 Investments in Venezuelan bonds
(11,818 ) - NET CASH USED IN INVESTING ACTIVITIES
(151,765 ) (91,661 ) CASH FLOWS FROM FINANCING
ACTIVITIES Dividends paid (30,400 ) (92,651 ) Dividends received
3,416 - Payments for Capped Call Transactions (123,825 ) -
Borrowings from senior secured credit facility and other debt -
763,232 Proceeds from senior convertible notes 1,150,000 -
Principal payments on senior secured credit facility and other debt
(56,250 ) (300,733 ) Issuance costs relating to long-term debt and
senior convertible notes (28,927 ) - Share repurchases (1,278,420 )
(275,821 ) Excess (deficiency in) tax benefits from share-based
payment arrangements 4,176 (2,586 ) Proceeds from exercise of stock
options and sale of stock under employee stock purchase plan
2,401 975 NET CASH (USED IN) PROVIDED BY
FINANCING ACTIVITIES (357,829 ) 92,416 EFFECT
OF EXCHANGE RATE CHANGES ON CASH (234,743 ) (18,725 )
NET CHANGE IN CASH AND CASH EQUIVALENTS (294,840 ) 559,014 CASH AND
CASH EQUIVALENTS, BEGINNING OF PERIOD 972,974
333,534 CASH AND CASH EQUIVALENTS, END OF PERIOD
678,134 892,548 CASH PAID DURING THE PERIOD
Interest paid $ 31,512 $ 18,005 Income taxes paid $
152,698 $ 163,843 NON CASH ACTIVITIES Accrued capital
expenditures $ 10,939 $ 7,705
SUPPLEMENTAL INFORMATION
SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL
MEASURES(unaudited and unreviewed), (Dollars in Thousand,
Except Per Share Data)
In addition to its reported results, the Company has included
in the tables below adjusted results that the Securities and
Exchange Commission defines as “non-GAAP financial measures.”
Management believes that such non-GAAP financial measures, when
read in conjunction with the Company’s reported results, can
provide useful supplemental information for investors in analyzing
period to period comparisons of the Company’s results.
The following is a reconciliation of net
income, presented and reported in accordance with U.S. generally
accepted accounting principles, to net income adjusted for certain
items:
Three Months Ended Nine Months
Ended
9/30/14
9/30/13
9/30/14
9/30/13
(in thousands) Net income, as reported $ 11,248 $ 141,950 $
205,408 $ 403,985 Remeasurement and impairment losses relating to
Venezuela (1)(2) 83,717 12 152,878 8,319 Expenses incurred
responding to attacks on the Company's business model (1)(3) 4,543
5,485 13,459 20,589 Expenses incurred for the re-audit of 2010 to
2012 financial statements (1)(4) - 4,640 - 7,301 Expenses related
to the FTC inquiry (1)(5) 2,776 - 6,541 - Expenses incurred for the
recovery of re-audit fees (1)(6) (33 ) - 378 -
Non-cash interest expense and amortization
of non-cash issuance costs (7)
9,927 - 25,936 - Legal reserve for the Bostick case (1)(8) 11,279 -
11,279 - Impairment of newly acquired defective manufacturing
equipment (1)(9) 1,651 - 1,651 -
Net income, as adjusted $ 125,108 $ 152,087 $ 417,530 $
440,194
The following is a reconciliation of
diluted earnings per share, presented and reported in accordance
with U.S. generally accepted accounting principles, to diluted
earnings per share adjusted for certain items:
Three Months Ended Nine Months Ended
9/30/14
9/30/13
9/30/14
9/30/13
Diluted earnings per share, as reported $ 0.13 $ 1.32 $ 2.22
$ 3.75 Remeasurement loss relating to Venezuela (1)(2) 0.97 - 1.65
0.08 Expenses incurred responding to attacks on the Company's
business model (1)(3) 0.05 0.05 0.15 0.19 Expenses incurred for the
re-audit of 2010 to 2012 financial statements (1)(4) - 0.04 - 0.07
Expenses related to the FTC inquiry (1)(5) 0.03 - 0.07 - Expenses
incurred for the recovery of re-audit fees (1)(6) - - - -
Non-cash interest expense and amortization
of non-cash issuance costs (7)
0.12 - 0.28 - Legal reserve for the Bostick case (1)(8) 0.13 - 0.12
- Impairment of newly acquired defective manufacturing equipment
(1)(9) 0.02 - 0.02 -
Diluted earnings per share, as adjusted
(10)
$ 1.45 $ 1.41 $ 4.51 $ 4.08
(1) Based on interim income tax reporting
rules, these expenses are not considered discrete items. As a
result, the Company's full year effective tax rate is impacted by
these items. When applying the full year effective tax rate to
year-to-date income, the Company's year-to-date tax provision
recorded with respect to these non-GAAP adjustments is different
from the forecasted full-year tax provision impact of these items.
As a consequence, adjustments to the year-to-date and quarterly tax
impacts will be recorded as the adjusted full year effective tax
rate is applied to income in subsequent periods. Additionally,
adjustments to items unrelated to these non-GAAP adjustments may
have an effect on the income tax impact of these non-GAAP
adjustments in subsequent periods. The Company plans to update the
income tax impact of these items in subsequent interim reporting
periods.
(2) Net of $55,801 and $(12) tax benefit
for the three months ended Sept. 30, 2014 and 2013, respectively;
and net of $76,118 and $6,796 tax benefit for the nine months ended
Sept. 30, 2014 and 2013, respectively.
(3) Net of $1,461 and $773 tax benefit for
the three months ended Sept. 30, 2014 and 2013, respectively; and
net of $4,827 and $3,241 tax benefit for the nine months ended
Sept. 30, 2014 and 2013, respectively.
(4) Net of $1,533 and $2,329 tax benefit for the three and nine
months ended Sept. 30, 2013, respectively. (5) Net of $1,817 and
$4,095 tax benefit for the three and nine months ended Sept. 30,
2014, respectively. (6) Net of $93 and $96 tax benefit for the
three and nine months ended Sept. 30, 2014, respectively. (7)
Relates to non-cash expense on our convertible notes and prepaid
forward share repurchase contract. (8) Net of $6,221 tax benefit
for the three and nine months ended Sept. 30, 2014. (9) Net of $913
tax benefit for the three and nine months ended Sept. 30, 2014.
(10) Amounts may not total due to rounding.
The following is a reconciliation of total long-term debt to net
debt:
9/30/14
12/31/13
Total long-term debt (current and long-term portion)
$ 1,827,919 $ 931,269 Less: Cash and cash equivalents
678,134 972,974 Net debt $ 1,149,785 $
(41,705 )
Herbalife Ltd.Media Contact:Julian CacchioliVP, Worldwide Corp.
Comm.213-745-0519orInvestor Contact:Amy GreeneSVP, Investor
Relations213-745-0474
Herbalife (NYSE:HLF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Herbalife (NYSE:HLF)
Historical Stock Chart
From Apr 2023 to Apr 2024